In the clinical practice a physician quite often is at a loss due to "freedom of choice" granted by availability of direct oral anticoagulants (DOAC). If a patient with nonvalvular atrial fibrillation (AF) has indications for therapy with anticoagulants which DOAC should be preferred? What are benefits for a patient with ischemic heart disease and AF when definite NOAC is chosen and what are risks inherent of this choice? Answers to such questions are given in this paper.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
atrial fibrillation
8
ischemic heart
8
anticoagulants doac
8
[tactics selection
4
selection anticoagulant
4
anticoagulant therapy
4
therapy patients
4
patients atrial
4
fibrillation ischemic
4
heart disease]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!